Moderate volume — adequate liquidity for most positions
Price strongly directional — lower volatility expected
Exchange-standard resolution criteria
Standard manipulation risk for this market depth
Resolves in ~231d — long horizon, capital lock-up risk
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and Decemb...